Summary
VITALIX LAB is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €5.6m and a net result of -€362,833. Equity is shrinking by about 25% per year across the filed financial years. Its solvency ranks better than 70% of 6,655 sector peers (NACE 64, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
What the company does
- Name clauseThe name the company operates under according to its articles.
- VITALIX LAB
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Tenir compte,dans la prise de décision,de la réalisation,à court et à (moyen) long terme,d’un impact positif significatif au travers des…” (deed in French)